Neonatal Thyrotoxicosis — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Neonatal Graves disease due to transplacental passage of maternal TSH receptor stimulating antibodies
Neonatal thyrotoxicosis from transplacental passage of maternal TSH receptor antibodies (TRAb) typically presents at birth or within the first 2 weeks. It is usually self-limiting (as maternal antibodies clear by 3-6 months) but can be severe. Treatment includes carbimazole and propranolol. Lugol's iodine may be needed for severe cases.
Reference: RCH Melbourne – 2024 – Clinical Practice Guidelines: Neonatal Thyrotoxicosis